VTR Stock Recent News

VTR LATEST HEADLINES

VTR Stock News Image - Seeking Alpha

Ventas, a healthcare REIT, has underperformed the market due to the pandemic and high interest rates. The company is starting to recover, with strong demand for its properties and favorable supply-demand fundamentals. Analysts expect Ventas to grow its FFO per unit by 7% per year, and the stock is reasonably valued with upside potential.

Seeking Alpha 2023 Nov 21
VTR Stock News Image - Seeking Alpha

Ventas beats Q3'23 earnings estimates with FFO/share of $0.75 and revenue of $1.15bn. Wedbush and BMO Capital Markets upgrade or maintain outperform rating on Ventas. Ventas focuses on senior care and healthcare real estate, combining growth and security.

Seeking Alpha 2023 Nov 21
VTR Stock News Image - The Motley Fool

Ventas reported respectable third-quarter earnings, with strength in its senior housing business. Welltower reported good quarterly results as well.

The Motley Fool 2023 Nov 12
VTR Stock News Image - Zacks Investment Research

Ventas's (VTR) Q3 earnings outshine estimates on better-than-anticipated revenues. The same-store cash NOI rises year over year on strong performance across the portfolio.

Zacks Investment Research 2023 Nov 03
VTR Stock News Image - Seeking Alpha

Ventas, Inc. (NYSE:VTR ) Q3 2023 Earnings Conference Call November 3, 2023 10:00 AM ET Company Participants BJ Grant - SVP, IR Debra Cafaro - Chairman and CEO Justin Hutchens - CIO and EVP, Senior Housing Bob Probst - EVP and CFO Pete Bulgarelli - EVP and President and CEO, Lillibridge Healthcare Services, Inc. Conference Call Participants Austin Wurschmidt - KeyBanc Capital Markets Steve Sakwa - Evercore ISI Nick Joseph - Citi Juan Sanabria - BMO Capital Markets Mike Mueller - JPMorgan Ronald Kamdem - Morgan Stanley Joshua Dennerlein - Bank of America Rich Anderson - Wedbush Michael Stroyeck - Green Street Vikram Malhotra - Mizuho Nick Yulico - Scotiabank Michael Carroll - RBC Capital Markets Operator Thank you for standing by and welcome to the Ventas Reports Third Quarter Results Conference Call. I would now like to welcome BJ Grant, Senior Vice President of Investor Relations to begin the call.

Seeking Alpha 2023 Nov 03
VTR Stock News Image - Zacks Investment Research

Although the revenue and EPS for Ventas (VTR) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research 2023 Nov 02
VTR Stock News Image - Business Wire

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) will issue its third quarter 2023 earnings release after the close of trading on the New York Stock Exchange on Thursday, November 2, 2023. A conference call to discuss those earnings will be held on Friday, November 3, 2023, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode i.

Business Wire 2023 Oct 18
VTR Stock News Image - Seeking Alpha

Senior housing is experiencing strong fundamentals with rebounding occupancy, stronger rental rates, and double-digit NOI growth. Rapid growth is expected in the 80+ year old demographic over the coming years, generating meaningful demand uplift in Senior Housing. Simultaneously, rising construction and financing costs have kept a lid on new development.

Seeking Alpha 2023 Oct 03
VTR Stock News Image - Seeking Alpha

Healthcare REIT Ventas Inc. is an attractive investment for passive income investors due to long-term aging trends and post-pandemic recovery. The trust's well-managed properties generate strong cash flow, suggesting potential for dividend growth. Ventas' Senior Living segment is experiencing a strong recovery, with potential for significant net operating income growth and a re-rating of the stock.

Seeking Alpha 2023 Sep 12
VTR Stock News Image - WSJ

After an unsuccessful proxy fight in 2022, the activist sets up what could be its second campaign at the big healthcare REIT.

WSJ 2023 Sep 10
10 of 50